M. Mansour, P. Palese, D. Zamarin: Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells. In: Journal of Virology. Band85, Nr.12, 15. Juni 2011, ISSN0022-538X, S.6015–6023, doi:10.1128/JVI.01537-10, PMID 21471241, PMC 3126310 (freier Volltext) – (asm.org [abgerufen am 23. Juni 2020]).
LaszloK Csatary: VIRUSES IN THE TREATMENT OF CANCER. In: The Lancet. Band298, Nr.7728, Oktober 1971, S.825, doi:10.1016/S0140-6736(71)92788-7 (elsevier.com [abgerufen am 23. Juni 2020]).
M. Mansour, P. Palese, D. Zamarin: Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells. In: Journal of Virology. Band85, Nr.12, 15. Juni 2011, ISSN0022-538X, S.6015–6023, doi:10.1128/JVI.01537-10, PMID 21471241, PMC 3126310 (freier Volltext) – (asm.org [abgerufen am 23. Juni 2020]).
elsevier.com
linkinghub.elsevier.com
LaszloK Csatary: VIRUSES IN THE TREATMENT OF CANCER. In: The Lancet. Band298, Nr.7728, Oktober 1971, S.825, doi:10.1016/S0140-6736(71)92788-7 (elsevier.com [abgerufen am 23. Juni 2020]).
L. K. Csatary, R. W. Moss, J. Beuth, B. Töröcsik, J. Szeberenyi, T. Bakacs: Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H). In: Anticancer Research. 19 (1B), 1999, S.635–638, PMID 10216468.
M. Mansour, P. Palese, D. Zamarin: Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells. In: Journal of Virology. Band85, Nr.12, 15. Juni 2011, ISSN0022-538X, S.6015–6023, doi:10.1128/JVI.01537-10, PMID 21471241, PMC 3126310 (freier Volltext) – (asm.org [abgerufen am 23. Juni 2020]).
M. Mansour, P. Palese, D. Zamarin: Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells. In: Journal of Virology. Band85, Nr.12, 15. Juni 2011, ISSN0022-538X, S.6015–6023, doi:10.1128/JVI.01537-10, PMID 21471241, PMC 3126310 (freier Volltext) – (asm.org [abgerufen am 23. Juni 2020]).